Drug profile · INN
alfuzosin hydrochloride
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride (ALFUZOSIN HYDROCHLORIDE) is a adrenergic receptor alpha-1 agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — alfuzosin hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
alfuzosin hydrochloride (ALFUZOSIN HYDROCHLORIDE) is a adrenergic receptor alpha-1 agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha-1 agonist
Primary target: Adrenergic receptor alpha-1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is alfuzosin hydrochloride?
alfuzosin hydrochloride (ALFUZOSIN HYDROCHLORIDE) is a adrenergic receptor alpha-1 agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for alfuzosin hydrochloride?
ALFUZOSIN HYDROCHLORIDE is a marketed brand name for alfuzosin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of alfuzosin hydrochloride?
alfuzosin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.